The Schulte Group - Systems Biology of Cancer
The Schulte Group investigates therapy options arising from the nucleolar stress response, complementing insight from the polygenic model of BRCA2-deficient solid cancer and monogenic stress induction by Fusion Gene Sarcoma (FUS). They aim to identify the common end path of the malignant status.
The Schulte Group is funded by the Max Lindermann Memorial Foundation, Miami, The Alexander Pigott Wernher Foundation, London, ACT Cancer Council, and private donations.
- Professor Stefan Bornstein, TransCampus Dresden-London
- Professor Robin Jones, The Royal Marsden Hospital London